Internal Medicine, Endocrinology, Diabetes, & Metabolism · Hammond, LA
NPI
1295707669
Since 2006
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
15770 Paul Vega MD Dr, 202
Hammond, LA, 70403
Phone (985) 429-8168
Groups this clinician bills Medicare through
Medicare paid, 2024
$100K
1,186 services
Medicare patients, 2024
536
Average age 73
Drug cost, 2024
$6.6M
12,016 prescriptions
Company payments, 2025
$8,320
From 34 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Harold J Miller was code 99214 (office e&m - established), 781 times for 490 patients. In total Harold J Miller billed 1,186 services in 10 codes, and Medicare paid $100K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2008-07-24.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 781 | 490 | $96.33 | $75K |
| 95251 Test - Miscellaneous | Office | 167 | 93 | $26.55 | $4,434 |
| 76536 Ultrasound - Nonspecific | Office | 109 | 98 | $81.00 | $8,829 |
| 99233 Hospital E&M - Subsequent | Facility | 56 | 23 | $88.86 | $4,976 |
| 99204 Office E&M - New | Office | 33 | 33 | $128.22 | $4,231 |
| 99223 Hospital E&M - Initial | Facility | 15 | 15 | $129.73 | $1,946 |
By year: 2022 $105K for 1,290 services; 2023 $96K for 1,156 services; 2024 $100K for 1,186 services.
Medicare prescription drug claims, 2024
In 2024, the drug Harold J Miller prescribed most often to Medicare patients was Levothyroxine Sodium, with 1,178 prescriptions and refills. In total Harold J Miller wrote 12,016 Medicare prescriptions that cost $6.6M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Levothyroxine Sodium Generic | 1,178 | 2,983 | 300 | $11K |
| Mounjaro Tirzepatide | 467 | 593 | 76 | $623K |
| Metformin Hcl Er Metformin Hcl | 457 | 1,138 | 128 | $4,956 |
| Synthroid Levothyroxine Sodium | 401 | 686 | 79 | $28K |
| Metformin Hcl Generic | 390 | 1,015 | 106 | $2,435 |
| Ozempic Semaglutide | 364 | 465 | 80 | $429K |
| Glimepiride Generic | 324 | 815 | 85 | $2,797 |
| Jardiance Empagliflozin | 319 | 426 | 52 | $245K |
| Lantus Solostar Insulin Glargine,hum.Rec.Anlog | 309 | 563 | 83 | $50K |
| Novolog Insulin Aspart | 300 | 367 | 54 | $66K |
| Nateglinide Generic | 246 | 471 | 56 | $13K |
| Liothyronine Sodium Generic | 183 | 407 | 51 | $6,112 |
| Novolog Flexpen Insulin Aspart | 154 | 274 | 56 | $35K |
| Nano 2nd Gen Pen Needle Pen Needle, Diabetic | 151 | 325 | 57 | $15K |
| Tradjenta Linagliptin | 151 | 225 | 32 | $112K |
Brand drugs: 5,325 claims; generic drugs: 5,886 claims; opioid claims: 90.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Harold J Miller $8,320 ($6,824 in general payments such as food, travel and fees and $1,496 for research) from 34 companies. The largest payer was Insulet Corporation with $2,117.
| Company | Payments | Amount |
|---|---|---|
| Insulet Corporation PODD | 21 | $2,117 |
| Corcept Therapeutics CORT | 20 | $2,048 |
| Dexcom, Inc. DXCM | 20 | $458 |
| Xeris Pharmaceuticals, Inc. | 27 | $394 |
| Recordati_rare_diseases_inc. | 12 | $353 |
| Beta Bionics, Inc. BBNX | 8 | $300 |
| Abbott Laboratories ABT | 15 | $264 |
| Amgen Inc. AMGN | 13 | $258 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 11 | $242 |
| Medtronic, Inc. MDT | 10 | $226 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.